Segment and Geographical Information (Tables)

6 Months Ended

Mar. 31, 2019

Segment Reporting [Abstract]

Segment Revenue, Operating Income (Loss) and Depreciation and Amortization

The tables below present segment revenue, operating income (loss) and depreciation and amortization, as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(Dollars in thousands)	2019			2018			2019			2018
Revenue:
Medical Device	$	17,301		$	14,052		$	34,559		$	26,826
In Vitro Diagnostics		5,375			5,006			10,358			9,245
Total revenue	$	22,676		$	19,058		$	44,917		$	36,071
Operating income (loss):
Medical Device	$	(23	)	$	232		$	334		$	(157	)
In Vitro Diagnostics		2,915			2,423			5,370			4,093
Total segment operating income		2,892			2,655			5,704			3,936
Corporate		(2,027	)		(2,130	)		(4,127	)		(4,044	)
Total operating income (loss)	$	865		$	525		$	1,577		$	(108	)
Depreciation and amortization:
Medical Device	$	1,447		$	1,324		$	2,835		$	2,596
In Vitro Diagnostics		117			100			233			190
Corporate		255			162			507			320
Total depreciation and amortization	$	1,819		$	1,586		$	3,575		$	3,106